Overview of vitiligo research October - December 2013

This is a review of research results in the vitiligo field for the period from October 2013 till December 2013 from our Chief Scientific Director Dr. Igor Korobko.


  • Central role of IFN-gamma but not that of TNF-alpha in vitiligo development is further confirmed.
  • Regulatory T-cell role in vitiligo pathogenesis demonstrated again.
  • Proton pump inhibitors might aggravate vitiligo. The first case of vitiligo induction upon gefitinib treatment is reported.
  • Additional evidence on efficient treatment of segmental vitiligo by routinely used non-surgical methods was provided, but early-after-onset disease treatment seems to be required for success.

The full report is available for download in pdf.

image description

I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.


Famous vitiligans


All FAQs

To download this free file, please tell us a little bit about yourself.